Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study
BMC Cancer
.
2016 Jun 21;16(1):369.
doi: 10.1186/s12885-016-2403-1.
Authors
John Bridgewater
1
,
Andre Lopes
2
,
Sandra Beare
2
,
Marian Duggan
2
,
Dymphna Lee
2
,
Maravic Ricamara
3
,
Delyth McEntee
4
,
Ajithkumar Sukumaran
5
,
Harpreet Wasan
5
,
Juan W Valle
4
Affiliations
1
UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK. j.bridgewater@ucl.ac.uk.
2
Cancer Research UK and UCL Clinical Trials Centre, London, UK.
3
UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK.
4
The Christie NHS Foundation Trust, Manchester, UK.
5
Imperial College Healthcare, London, UK.
PMID:
27328670
PMCID:
PMC4916533
DOI:
10.1186/s12885-016-2403-1
No abstract available
Publication types
Published Erratum
Grants and funding
15953/CRUK_/Cancer Research UK/United Kingdom